Key statistics
As of last trade, Carisma Therapeutics Inc (W2J:BER) traded at 0.8205, 12.17% above the 52 week low of 0.7315 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.8095 |
---|---|
High | 0.821 |
Low | 0.809 |
Bid | 0.75 |
Offer | 0.8885 |
Previous close | 0.8065 |
Average volume | 59.00 |
---|---|
Shares outstanding | 41.75m |
Free float | 29.28m |
P/E (TTM) | -- |
Market cap | 35.40m USD |
EPS (TTM) | -1.56 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:35 GMT.
More ▼
Press releases
- Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
- Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
- Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
- Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
- Carisma Therapeutics to Present at Upcoming Conferences
More ▼